364 related articles for article (PubMed ID: 2411866)
1. Regional differences in the coupling of muscarinic receptors to inositol phospholipid hydrolysis in guinea pig brain.
Fisher SK; Bartus RT
J Neurochem; 1985 Oct; 45(4):1085-95. PubMed ID: 2411866
[TBL] [Abstract][Full Text] [Related]
2. Pirenzepine distinguishes between muscarinic receptor-mediated phosphoinositide breakdown and inhibition of adenylate cyclase.
Gil DW; Wolfe BB
J Pharmacol Exp Ther; 1985 Mar; 232(3):608-16. PubMed ID: 2579230
[TBL] [Abstract][Full Text] [Related]
3. The putative M1 muscarinic receptor does not regulate phosphoinositide hydrolysis. Studies with pirenzepine and McN-A343 in chick heart and astrocytoma cells.
Brown JH; Goldstein D; Masters SB
Mol Pharmacol; 1985 May; 27(5):525-31. PubMed ID: 2581122
[TBL] [Abstract][Full Text] [Related]
4. Differential receptor occupancy requirements for muscarinic cholinergic stimulation of inositol lipid hydrolysis in brain and in neuroblastomas.
Fisher SK; Snider RM
Mol Pharmacol; 1987 Jul; 32(1):81-90. PubMed ID: 3600615
[TBL] [Abstract][Full Text] [Related]
5. Rat hippocampal muscarinic autoreceptors are similar to the M2 (cardiac) subtype: comparison with hippocampal M1, atrial M2 and ileal M3 receptors.
Richards MH
Br J Pharmacol; 1990 Apr; 99(4):753-61. PubMed ID: 1694463
[TBL] [Abstract][Full Text] [Related]
6. Muscarinic receptor coupling to inositol phospholipid metabolism in guinea-pig cerebral cortex, parotid gland and ileal smooth muscle.
Ek B; Nahorski S
Biochem Pharmacol; 1988 Dec; 37(23):4461-7. PubMed ID: 2849446
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the subtype of muscarinic receptor coupled to the stimulation of phosphoinositide hydrolysis in 132-1N1 human astrocytoma cells.
Stephan CC; Sastry BV
Cell Mol Biol (Noisy-le-grand); 1992 Nov; 38(7):701-12. PubMed ID: 1282058
[TBL] [Abstract][Full Text] [Related]
8. Distinct muscarinic receptor subtypes differentially modulate acetylcholine release from corticocerebral synaptosomes.
Pittel Z; Heldman E; Rubinstein R; Cohen S
J Neurochem; 1990 Aug; 55(2):665-72. PubMed ID: 1695243
[TBL] [Abstract][Full Text] [Related]
9. Postsynaptic integration of cholinergic and dopaminergic signals on medium-sized GABAergic projection neurons in the neostriatum.
Harsing LG; Zigmond MJ
Brain Res Bull; 1998 Apr; 45(6):607-13. PubMed ID: 9566505
[TBL] [Abstract][Full Text] [Related]
10. On the involvement of multiple muscarinic receptor subtypes in the activation of phosphoinositide metabolism in rat cerebral cortex.
Forray C; el-Fakahany EE
Mol Pharmacol; 1990 Jun; 37(6):893-902. PubMed ID: 2163015
[TBL] [Abstract][Full Text] [Related]
11. Muscarinic receptors in canine colonic circular smooth muscle. II. Signal transduction pathways.
Zhang LB; Buxton IL
Mol Pharmacol; 1991 Dec; 40(6):952-9. PubMed ID: 1661840
[TBL] [Abstract][Full Text] [Related]
12. Regulation of muscarinic receptor subtypes and their responsiveness in rat brain following chronic atropine administration.
Lee W; Wolfe BB
Mol Pharmacol; 1989 Nov; 36(5):749-57. PubMed ID: 2555673
[TBL] [Abstract][Full Text] [Related]
13. Differential stimulation of inositol phospholipid turnover in brain by analogs of oxotremorine.
Fisher SK; Figueiredo JC; Bartus RT
J Neurochem; 1984 Oct; 43(4):1171-9. PubMed ID: 6088696
[TBL] [Abstract][Full Text] [Related]
14. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. I. Characterization and regulation of agonist binding to putative muscarinic subtypes.
Watson M; Yamamura HI; Roeske WR
J Pharmacol Exp Ther; 1986 May; 237(2):411-8. PubMed ID: 3754580
[TBL] [Abstract][Full Text] [Related]
15. Enhanced coupling of neonatal muscarinic receptors in rat brain to phosphoinositide turnover.
Heacock AM; Fisher SK; Agranoff BW
J Neurochem; 1987 Jun; 48(6):1904-11. PubMed ID: 3033155
[TBL] [Abstract][Full Text] [Related]
16. Pharmacologic characterization and functional role of muscarinic autoreceptors in the rabbit striatum.
James MK; Cubeddu LX
J Pharmacol Exp Ther; 1987 Jan; 240(1):203-15. PubMed ID: 3806384
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological basis for functional selectivity of partial muscarinic receptor agonists.
Heldman E; Barg J; Fisher A; Levy R; Pittel Z; Zimlichman R; Kushnir M; Vogel Z
Eur J Pharmacol; 1996 Feb; 297(3):283-91. PubMed ID: 8666061
[TBL] [Abstract][Full Text] [Related]
18. Developmental changes in muscarinic receptor-stimulated phosphoinositide metabolism in rat brain.
Balduini W; Murphy SD; Costa LG
J Pharmacol Exp Ther; 1987 May; 241(2):421-7. PubMed ID: 3033215
[TBL] [Abstract][Full Text] [Related]
19. Long-term atropine treatment lowers the efficacy of carbachol to stimulate phosphatidylinositol breakdown in the cerebral cortex and hippocampus of rats.
Goobar L; Bartfai T
Biochem J; 1988 Mar; 250(3):727-34. PubMed ID: 3390140
[TBL] [Abstract][Full Text] [Related]
20. Gallamine binding to muscarinic M1 and M2 receptors, studied by inhibition of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to rat brain membranes.
Burke RE
Mol Pharmacol; 1986 Jul; 30(1):58-68. PubMed ID: 3755217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
